A1BG-AS1 promotes the biological functions of osteosarcoma cells via regulating the microRNA-148a-3p/USP22 axis and stabilizing the expression of SIRT1 through deubiquitinase function-Reference-Cited by-同舟云学术

A1BG-AS1 promotes the biological functions of osteosarcoma cells via regulating the microRNA-148a-3p/USP22 axis and stabilizing the expression of SIRT1 through deubiquitinase function

Published:2023-10-03 Issue:10 Volume:27 Page:1017-1029
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Han Xiuxin¹,Yin Mengfan¹²,Gong Chen³,Zhang Chao¹,Zhu Genbao³,Hu Mengxue³,Tan Kemeng³,Jiang La³,Wang Guowen¹,Li Lili³

Affiliation:

1. Department of Bone and Soft Tissue Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center of Cancer, Tianjin, China

2. Department of Orthopedic Surgery, Tianjin Fifth Central Hospital, Tianjin, China

3. General Clinical Research Center, Anhui Wanbei Coal-Electricity Group General Hospital, Suzhou, Anhui, China

Funder

no specific grant

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2023.2263908

Reference33 articles.

1. Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs